The present study is ideated to prospectively investigate in patients with severe acute respiratory syndrome (SARS) due to Coronavirus 19 (SARS-Cov-2) infection and moderate-severe respiratory failure the patterns and changes in platelet reactivity, thrombotic status and endothelial function. The observed patterns and changes will be related with inflammatory status, myocardial injury and outcomes
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
on-treatment platelet reactivity
Timeframe: early stage of disease (first 96 hours)
on-treatment platelet reactivity
Timeframe: mid stage of disease (96 hours - 14 days)
on-treatment platelet reactivity
Timeframe: late stage of disease (>14 days)